Finance

Lists
Why is BAX up २.२१%?
Dive Deeper
BAX:NYSE
Baxter International Inc
US$ २४.००
+२.२१%
(+०.५२) 1D
US$ २४.१०
+०.४२% (+०.१०)
After hours
Closed: सेप्टेम्बर ३०, १६:००:१० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Open
US$ २३.५०
High
US$ २४.१०
Low
US$ २३.३६
Mkt. cap
१२.४१ अरब
Avg. vol.
५९.५७ लाख
Volume
३४.००
Dividend
०.१७%
Quarterly dividend
US$ ०.०१
Ex-dividend date
२०२६ अगस्ट २८
52-wk high
US$ ३०.००
52-wk low
US$ १५.७३
EPS
-US$ २.०७
Beta
०.६०
Shares outstanding
५१.७० करोड
No. of employees
३८ हजार
Open
US$ २३.५०
High
US$ २४.१०
Low
US$ २३.३६
Mkt. cap
१२.४१ अरब
Avg. vol.
५९.५७ लाख
Volume
३४.००
Dividend
०.१७%
Quarterly dividend
US$ ०.०१
Ex-dividend date
२०२६ अगस्ट २८
52-wk high
US$ ३०.००
52-wk low
US$ १५.७३
EPS
-US$ २.०७
Beta
०.६०
Shares outstanding
५१.७० करोड
No. of employees
३८ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
२० घण्टा पहिले
Baxter International stock faces a Q3 EPS estimate cut
AD HOC NEWS
AD HOC NEWS
·
२ दिन पहिले
Baxter International stock trades above analyst target
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees३७.५ हजार
Founded१९३१
HeadquartersDeerfield, इलिनोइ, संयुक्त राज्य अमेरिका
Sector-
Websitebaxter.com
Analyst ratings
Based on 10 analysts giving stock ratings to BAX in the past 3 months
Hold
Buy
1
Hold
9
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BAX in the last 3 months.
Highest
Current US$ २४.००
US$ २९.०० (+२०.८३%)
Average
US$ २५.९० (+७.९२%)
Lowest
US$ २१.०० (-१२.५०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Hold
Maintained
US$ २८.००
+१६.७%
08/13/2026
Travis Steed
Bank of America Securities
Hold
Maintained
US$ २८.००
+१६.७%
08/11/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
US$ २६.००
+८.३%
08/06/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
US$ २७.००
+१२.५%
07/31/2026
Josh Jennings
TD Cowen
Hold
Maintained
US$ २९.००
+२०.८%
07/31/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
US$ २३.००
-४.२%
07/31/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
US$ २८.००
+१६.७%
07/31/2026
Danielle Antalffy
UBS
Hold
Reiterated
US$ २५.००
+४.२%
07/28/2026
Patrick Wood
UBS
Hold
Reiterated
US$ २५.००
+४.२%
07/28/2026
David Roman
Goldman Sachs
Hold
Reiterated
US$ २१.००
-१२.५%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$ २४.००
०%
07/06/2026
Steven Silver
Argus Research
Hold
Maintained
-
-
05/08/2026
Matt Miksic
Barclays
Buy
Maintained
US$ २७.००
+१२.५%
05/04/2026
Matthew Taylor
Jefferies
Hold
Reiterated
US$ १९.००
-२०.८%
02/12/2026
Last report
२०२६ जुलाई ३०
Fiscal period
Q2 2026
EPS / Est. (USD)
US$ ०.५६ / US$ ०.३७
+५२.५३%beat
Revenue / Est. (USD)
२.९६ अरब / २.८० अरब
+५.८८%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.८४ अरब
२.९७ अरब
२.७० अरब
२.९६ अरब
Cost of goods sold
१.८१ अरब
२.०१ अरब
१.८० अरब
१.८२ अरब
Cost of revenue
१.८१ अरब
२.०१ अरब
१.८० अरब
१.८२ अरब
Research and development expenses
११.५० करोड
११.६० करोड
१२.४० करोड
१२.५० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६६.९० करोड
६७.५० करोड
६५.८० करोड
६४.२० करोड
Operating expense
७३.४० करोड
७४.१० करोड
७३.५० करोड
७१.५० करोड
Total operating expenses
२.५५ अरब
२.७६ अरब
२.५४ अरब
२.५३ अरब
Operating income
२८.७० करोड
२१.९० करोड
१६.३० करोड
४२.७० करोड
Other non operating income
२०.०० लाख
३०.०० लाख
-१०.०० लाख
१०.०० लाख
EBT including unusual items
१२.१० करोड
-७५.६० करोड
-६०.०० लाख
१५.८० करोड
EBT excluding unusual items
२२.८० करोड
१६.१० करोड
९.३० करोड
३६.४० करोड
Income tax expense
१७.२० करोड
२७.९० करोड
१.१० करोड
२.३० करोड
Effective tax rate
१४२.१५%
-३६.९०%
-१८३.३३%
१४.५६%
Other operating expenses
-५.०० करोड
-५.०० करोड
-४.७० करोड
-५.२० करोड
Net income
-४.६० करोड
-१.१३ अरब
-१.५० करोड
१२.६० करोड
Net profit margin
-१.६२%
-३७.९३%
-०.५६%
४.२६%
Earnings per share
०.६९
०.४४
०.३६
०.५६
Interest and investment income
१.०० करोड
१.१० करोड
१.२० करोड
१.३० करोड
Interest expense
-६.८० करोड
-६.९० करोड
-७.८० करोड
-७.७० करोड
Net interest expenses
-५.८० करोड
-५.८० करोड
-६.६० करोड
-६.४० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५२.४० करोड
४५.९० करोड
४०.०० करोड
६६.६० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू